ERBB2 and breast cancer: Most of the patients expressed oestrogen receptor- (ER, 97.4%) and progesterone receptor- (PR, 91.9%) positive breast cancer, whereas human epidermal growth factor receptor 2 (HER2) overexpression was observed in 14.5%.